|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018061,
umls-concept:C0019932,
umls-concept:C0021102,
umls-concept:C0024501,
umls-concept:C0121902,
umls-concept:C0243192,
umls-concept:C0439231,
umls-concept:C0547043,
umls-concept:C0721534,
umls-concept:C0936223,
umls-concept:C1283071,
umls-concept:C1513054,
umls-concept:C1704229,
umls-concept:C1705604
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-3-16
|
|
pubmed:abstractText |
The administration of gonadotropin hormone-releasing hormone agonists is well established for treating metastatic prostate cancer. In an ongoing study we evaluated the effect of a long acting implant that releases the gonadotropin hormone-releasing hormone agonist histrelin ([ImBzl]D-His6,Pro9-Net) in 15 patients with disseminated prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
163
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
838-44
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10687989-Aged,
pubmed-meshheading:10687989-Aged, 80 and over,
pubmed-meshheading:10687989-Androgen Antagonists,
pubmed-meshheading:10687989-Drug Implants,
pubmed-meshheading:10687989-Gonadotropin-Releasing Hormone,
pubmed-meshheading:10687989-Humans,
pubmed-meshheading:10687989-Male,
pubmed-meshheading:10687989-Middle Aged,
pubmed-meshheading:10687989-Neoplasm Metastasis,
pubmed-meshheading:10687989-Prostatic Neoplasms,
pubmed-meshheading:10687989-Time Factors
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.
|
|
pubmed:affiliation |
Department of Urology, Shaare Zedek Medical Center and Zer Laboratories, Jerusalem, Israel.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
